155 related articles for article (PubMed ID: 131728)
1. Effects of long-term restricted insulin production in obese-hyperglycemic (genotype ob/ob) mice.
Boozer CN; Mayer J
Diabetologia; 1976 May; 12(2):181-7. PubMed ID: 131728
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islets of obese hyperglycemic mice (ob/ob).
Tomita T; Doull V; Pollock HG; Krizsan D
Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
[TBL] [Abstract][Full Text] [Related]
3. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
4. Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob/ob mice.
Batchelor BR; Stern JS; Johnson PR; Mahler RJ
Metabolism; 1975 Jan; 24(1):77-91. PubMed ID: 122852
[TBL] [Abstract][Full Text] [Related]
5. Age dependent effects of oxytetracycline in ob/ob mice.
Dubuc PU; Willis PL
Diabetologia; 1978 Feb; 14(2):129-33. PubMed ID: 631457
[TBL] [Abstract][Full Text] [Related]
6. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR
Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
Recant L; Voyles NR; Luciano M; Pert CB
Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
[TBL] [Abstract][Full Text] [Related]
8. The effects of exercise and food restriction on obesity and diabetes in young ob/ob mice.
Dubuc PU; Cahn PJ; Willis P
Int J Obes; 1984; 8(3):271-8. PubMed ID: 6378818
[TBL] [Abstract][Full Text] [Related]
9. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
[TBL] [Abstract][Full Text] [Related]
10. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
[TBL] [Abstract][Full Text] [Related]
11. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse.
Lavine RL; Voyles N; Perrino PV; Recant L
Am J Physiol; 1977 Aug; 233(2):E86-90. PubMed ID: 329686
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes.
Irles E; Ñeco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal Á; Quesada I
Mol Cell Endocrinol; 2015 Mar; 404():46-55. PubMed ID: 25633666
[TBL] [Abstract][Full Text] [Related]
13. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
14. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
[TBL] [Abstract][Full Text] [Related]
15. Effect of serotonin reuptake inhibitor on syndrome development in obese hyperglycemic mice (Umeå ob/ob).
Thrybom T; Rooth P; Lindström P
Metabolism; 2001 Feb; 50(2):144-50. PubMed ID: 11229420
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet hypertrophy in spontaneous maturity onset obese-diabetic CBA/Ca mice.
Figueroa CD; Taberner PV
Int J Biochem; 1994; 26(10-11):1299-303. PubMed ID: 7851633
[TBL] [Abstract][Full Text] [Related]
17. Behavioral manipulation of the diabetic phenotype in ob/ob mice.
Surwit RS; Feinglos MN; Livingston EG; Kuhn CM; McCubbin JA
Diabetes; 1984 Jul; 33(7):616-8. PubMed ID: 6376217
[TBL] [Abstract][Full Text] [Related]
18. Development of insulin secretory function in young obese hyperglycemic mice (Umeå ob/ob).
Edvell A; Lindström P
Metabolism; 1995 Jul; 44(7):906-13. PubMed ID: 7616850
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR
Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
